David T. Howton, SVP, General Counsel at Sarepta Therapeutics, Inc. (SRPT), sold 100,000 shares at $136.46 ($13.6M) on 2018-07-16, disclosed to the SEC on 2018-07-17.
Open-market sale of $13.6M SRPT by SVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $136.46 | 3,096 | $422K | 3.1% |
| 2 | $136.46 | 3,096 | $422K | 3.1% |
| 3 | $136.46 | 9,056 | $1.2M | 9.1% |
| 4 | $136.46 | 9,056 | $1.2M | 9.1% |
| 5 | $136.46 | 37,848 | $5.2M | 37.8% |
| 6 | $136.46 | 37,848 |
| $5.2M |
| 37.8% |
| Total | $136.46 avg | 100,000 | $13.6M | 100% |
| Filing → |
| SLDB | SELL | 2026-02-02 | $486K | — | Filing → |
| SLDB | SELL | 2025-12-04 | $25K | — | Filing → |
| SLDB | SELL | 2025-02-18 | $22K | — | Filing → |